|
1
|
Tjong MC, Mak DY, Shahi J, Li GJ, Chen H
and Louie AV: Current Management and Progress in Radiotherapy for
Small Cell Lung Cancer. Front Oncol. 10:11462020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang S, Tang J, Sun T, Zheng X, Li J, Sun
H, Zhou X, Zhou C, Zhang H, Cheng Z, et al: Survival changes in
patients with small cell lung cancer and disparities between
different sexes, socioeconomic statuses and ages. Sci Rep.
7:13392017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takenaka T, Takenoyama M, Inamasu E,
Yoshida T, Toyokawa G, Nosaki K, Hirai F, Yamaguchi M, Shimokawa M,
Seto T, et al: Role of surgical resection for patients with limited
disease-small cell lung cancer. Lung Cancer. 88:52–56. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke JD, Dashwood RH and Ho E:
Multi-targeted prevention of cancer by sulforaphane. Cancer Lett.
269:291–304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Myzak MC and Dashwood RH: Chemoprotection
by sulforaphane: Keep one eye beyond Keap1. Cancer Lett.
233:208–218. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riedl MA, Saxon A and Diaz-Sanchez D: Oral
sulforaphane increases Phase II antioxidant enzymes in the human
upper airway. Clin Immunol. 130:244–251. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prochaska HJ, Santamaria AB and Talalay P:
Rapid detection of inducers of enzymes that protect against
carcinogens. Proc Natl Acad Sci USA. 89:2394–2398. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kallifatidis G, Rausch V, Baumann B, Apel
A, Beckermann BM, Groth A, Mattern J, Li Z, Kolb A, Moldenhauer G,
et al: Sulforaphane targets pancreatic tumour-initiating cells by
NF-kappaB-induced antiapoptotic signalling. Gut. 58:949–963. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Żuryń A, Litwiniec A, Safiejko-Mroczka B,
Klimaszewska-Wiśniewska A, Gagat M, Krajewski A, Gackowska L and
Grzanka D: The effect of sulforaphane on the cell cycle, apoptosis
and expression of cyclin D1 and p21 in the A549 non-small cell lung
cancer cell line. Int J Oncol. 48:2521–2533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SH, Park HJ and Moon DO: Sulforaphane
sensitizes human breast cancer cells to paclitaxel-induced
apoptosis by downregulating the NF-κB signaling pathway. Oncol
Lett. 13:4427–4432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh SV, Srivastava SK, Choi S, Lew KL,
Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, et
al: Sulforaphane-induced cell death in human prostate cancer cells
is initiated by reactive oxygen species. J Biol Chem.
280:19911–19924. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jackson SJ, Singletary KW and Venema RC:
Sulforaphane suppresses angiogenesis and disrupts endothelial
mitotic progression and microtubule polymerization. Vascul
Pharmacol. 46:77–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jee HG, Lee KE, Kim JB, Shin HK and Youn
YK: Sulforaphane inhibits oral carcinoma cell migration and
invasion in vitro. Phytother Res. 25:1623–1628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shan Y, Zhang L, Bao Y, Li B, He C, Gao M,
Feng X, Xu W, Zhang X and Wang S: Epithelial-mesenchymal
transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail,
ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J
Nutr Biochem. 24:1062–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P,
Thompson CB and Jiang X: Role of mitochondria in ferroptosis. Mol
Cell. 73:354–363.e3. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lo M, Wang YZ and Gout PW: The x(c)-
cystine/glutamate antiporter: A potential target for therapy of
cancer and other diseases. J Cell Physiol. 215:593–602. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cellular and molecular life sciences : CMLS.
73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu B, Chen XB, Ying MD, He QJ, Cao J and
Yang B: The role of ferroptosis in cancer development and treatment
response. Front Pharmacol. 8:9922017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Louandre C, Ezzoukhry Z, Godin C, Barbare
J-C, Mazière J-C, Chauffert B and Galmiche A: Iron-dependent cell
death of hepatocellular carcinoma cells exposed to sorafenib. Int J
Cancer. 133:1732–1742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shin D, Lee J, You JH, Kim D and Roh JL:
Dihydrolipoamide dehydrogenase regulates cystine
deprivation-induced ferroptosis in head and neck cancer. Redox
Biol. 30:1014182020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma S, Henson ES, Chen Y and Gibson SB:
Ferroptosis is induced following siramesine and lapatinib treatment
of breast cancer cells. Cell Death Dis. 7:e23072016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Slee EA, Zhu H, Chow SC, MacFarlane M,
Nicholson DW and Cohen GM: Benzyloxycarbonyl-Val-Ala-Asp (OMe)
fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the
processing of CPP32. Biochem J. 315:21–24. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Degterev A, Huang Z, Boyce M, Li Y, Jagtap
P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J:
Chemical inhibitor of nonapoptotic cell death with therapeutic
potential for ischemic brain injury. Nat Chem Biol. 1:112–119.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukami T, Iida A, Konishi K and Nakajima
M: Human arylacetamide deacetylase hydrolyzes ketoconazole to
trigger hepatocellular toxicity. Biochem Pharmacol. 116:153–161.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ahn CH, Hong KO, Jin B, Lee WW, Jung YC,
Lee H, Shin J-A, Cho S-D and Hong SD: Contribution of p38 MAPK
pathway to norcantharidin-induced programmed cell death in human
oral squamous cell carcinoma. Int J Mol Sci. 20:34872019.
View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Torii S, Shintoku R, Kubota C, Yaegashi M,
Torii R, Sasaki M, Suzuki T, Mori M, Yoshimoto Y, Takeuchi T, et
al: An essential role for functional lysosomes in ferroptosis of
cancer cells. Biochem J. 473:769–777. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Demedts IK, Vermaelen KY and van Meerbeeck
JP: Treatment of extensive-stage small cell lung carcinoma: Current
status and future prospects. Eur Respir J. 35:202–215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang JY: Apoptosis-based anticancer
drugs. Nat Rev Drug Discov. 1:101–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fisher MD and D'Orazio A; CIG Media Group,
: Irinotecan and cisplatin versus etoposide and cisplatin in
small-cell lung cancer: JCOG 9511. Clin Lung Cancer. 2:23–24. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Erasmus JJ, McAdams HP and Rossi SE:
Drug-induced lung injury. Semin Roentgenol. 37:72–81. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Clarke JD, Hsu A, Yu Z, Dashwood RH and Ho
E: Differential effects of sulforaphane on histone deacetylases,
cell cycle arrest and apoptosis in normal prostate cells versus
hyperplastic and cancerous prostate cells. Mol Nutr Food Res.
55:999–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. Oct 1–2020.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lo M, Ling V, Wang YZ and Gout PW: The xc-
cystine/glutamate antiporter: A mediator of pancreatic cancer
growth with a role in drug resistance. Br J Cancer. 99:464–472.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Torti SV and Torti FM: Iron and cancer:
More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Manz DH, Blanchette NL, Paul BT, Torti FM
and Torti SV: Iron and cancer: Recent insights. Ann N Y Acad Sci.
1368:149–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Daniels TR, Bernabeu E, Rodríguez JA,
Patel S, Kozman M, Chiappetta DA, Holler E, Ljubimova JY, Helguera
G and Penichet ML: The transferrin receptor and the targeted
delivery of therapeutic agents against cancer. Biochim Biophys
Acta. 1820:291–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shibata Y, Inoue S, Igarashi A, Yamauchi
K, Abe S, Aida Y, Nunomiya K, Sato M, Nakano H, Sato K, et al:
Elevated serum iron is a potent biomarker for spirometric
resistance to cigarette smoke among Japanese males: The Takahata
study. PLoS One. 8:e740202013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S,
Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada
K, Aguirre AJ, et al: Dependency of a therapy-resistant state of
cancer cells on a lipid peroxidase pathway. Nature. 547:453–457.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Krohn A, Ahrens T, Yalcin A, Plönes T,
Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani SA, et al:
Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC):
Phenotypical and functional differences associated with
Epithelial-Mesenchymal Transition (EMT) and DNA methylation
changes. PLoS One. 9:e1002492014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Roh JL, Kim EH, Jang HJ, Park JY and Shin
D: Induction of ferroptotic cell death for overcoming cisplatin
resistance of head and neck cancer. Cancer Lett. 381:96–103. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sestili P and Fimognari C: Cytotoxic and
antitumor activity of sulforaphane: The role of reactive oxygen
species. BioMed Res Int. 2015:4023862015. View Article : Google Scholar : PubMed/NCBI
|
